世界のミトコンドリアミオパチー診断・治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mitochondrial Myopathy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3824
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ミトコンドリアミオパチー診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ミトコンドリアミオパチー診断、ミトコンドリアミオパチー治療）、用途別市場規模（病院、クリニック、疾病研究開発機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ミトコンドリアミオパチー診断・治療の市場動向
・企業の競争状況、市場シェア
・ミトコンドリアミオパチー診断・治療の種類別市場規模（ミトコンドリアミオパチー診断、ミトコンドリアミオパチー治療）
・ミトコンドリアミオパチー診断・治療の用途別市場規模（病院、クリニック、疾病研究開発機関）
・ミトコンドリアミオパチー診断・治療の北米市場規模2016-2027（アメリカ、カナダ）
・ミトコンドリアミオパチー診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ミトコンドリアミオパチー診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ミトコンドリアミオパチー診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ミトコンドリアミオパチー診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Centogene、GeneDx、Ixchel Pharma、Khondrion、Mitobridge、NeuroVive Pharmaceutical、Reata Pharmaceuticals、Stealth Biotherapeutics）
・結論

Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate “ragged red” muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.
The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.

Market Analysis and Insights: Global Mitochondrial Myopathy Diagnosis & Treatment Market
The global Mitochondrial Myopathy Diagnosis & Treatment market size is projected to reach US$ 31 million by 2026, from US$ 21 million in 2019, at a CAGR of 5.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mitochondrial Myopathy Diagnosis & Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mitochondrial Myopathy Diagnosis & Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mitochondrial Myopathy Diagnosis & Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mitochondrial Myopathy Diagnosis & Treatment market.

Global Mitochondrial Myopathy Diagnosis & Treatment Scope and Market Size
Mitochondrial Myopathy Diagnosis & Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mitochondrial Myopathy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
itochondrial Myopathy Diagnosis
Mitochondrial Myopathy Treatment

Segment by Application
Hospitals
Clinics
Disease Research and Development Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Centogene
GeneDx
Ixchel Pharma
Khondrion
Mitobridge
NeuroVive Pharmaceutical
Reata Pharmaceuticals
Stealth Biotherapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 itochondrial Myopathy Diagnosis
1.2.3 Mitochondrial Myopathy Treatment
1.3 Market by Application
1.3.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Disease Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Perspective (2016-2027)
2.2 Mitochondrial Myopathy Diagnosis & Treatment Growth Trends by Regions
2.2.1 Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mitochondrial Myopathy Diagnosis & Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mitochondrial Myopathy Diagnosis & Treatment Industry Dynamic
2.3.1 Mitochondrial Myopathy Diagnosis & Treatment Market Trends
2.3.2 Mitochondrial Myopathy Diagnosis & Treatment Market Drivers
2.3.3 Mitochondrial Myopathy Diagnosis & Treatment Market Challenges
2.3.4 Mitochondrial Myopathy Diagnosis & Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Revenue
3.1.1 Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Revenue (2016-2021)
3.1.2 Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mitochondrial Myopathy Diagnosis & Treatment Revenue
3.4 Global Mitochondrial Myopathy Diagnosis & Treatment Market Concentration Ratio
3.4.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitochondrial Myopathy Diagnosis & Treatment Revenue in 2020
3.5 Mitochondrial Myopathy Diagnosis & Treatment Key Players Head office and Area Served
3.6 Key Players Mitochondrial Myopathy Diagnosis & Treatment Product Solution and Service
3.7 Date of Enter into Mitochondrial Myopathy Diagnosis & Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mitochondrial Myopathy Diagnosis & Treatment Breakdown Data by Type
4.1 Global Mitochondrial Myopathy Diagnosis & Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Type (2022-2027)

5 Mitochondrial Myopathy Diagnosis & Treatment Breakdown Data by Application
5.1 Global Mitochondrial Myopathy Diagnosis & Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size (2016-2027)
6.2 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type
6.2.1 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021)
6.2.2 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027)
6.2.3 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2027)
6.3 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application
6.3.1 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021)
6.3.2 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027)
6.3.3 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2027)
6.4 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country
6.4.1 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021)
6.4.2 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size (2016-2027)
7.2 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type
7.2.1 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2027)
7.3 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application
7.3.1 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2027)
7.4 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country
7.4.1 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type
8.2.1 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application
8.3.1 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Region
8.4.1 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size (2016-2027)
9.2 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type
9.2.1 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2027)
9.3 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application
9.3.1 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2027)
9.4 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country
9.4.1 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type
10.2.1 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application
10.3.1 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country
10.4.1 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.1.4 AbbVie Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Centogene
11.2.1 Centogene Company Details
11.2.2 Centogene Business Overview
11.2.3 Centogene Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.2.4 Centogene Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.2.5 Centogene Recent Development
11.3 GeneDx
11.3.1 GeneDx Company Details
11.3.2 GeneDx Business Overview
11.3.3 GeneDx Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.3.4 GeneDx Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.3.5 GeneDx Recent Development
11.4 Ixchel Pharma
11.4.1 Ixchel Pharma Company Details
11.4.2 Ixchel Pharma Business Overview
11.4.3 Ixchel Pharma Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.4.4 Ixchel Pharma Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.4.5 Ixchel Pharma Recent Development
11.5 Khondrion
11.5.1 Khondrion Company Details
11.5.2 Khondrion Business Overview
11.5.3 Khondrion Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.5.4 Khondrion Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.5.5 Khondrion Recent Development
11.6 Mitobridge
11.6.1 Mitobridge Company Details
11.6.2 Mitobridge Business Overview
11.6.3 Mitobridge Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.6.4 Mitobridge Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.6.5 Mitobridge Recent Development
11.7 NeuroVive Pharmaceutical
11.7.1 NeuroVive Pharmaceutical Company Details
11.7.2 NeuroVive Pharmaceutical Business Overview
11.7.3 NeuroVive Pharmaceutical Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.7.4 NeuroVive Pharmaceutical Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.7.5 NeuroVive Pharmaceutical Recent Development
11.8 Reata Pharmaceuticals
11.8.1 Reata Pharmaceuticals Company Details
11.8.2 Reata Pharmaceuticals Business Overview
11.8.3 Reata Pharmaceuticals Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.8.4 Reata Pharmaceuticals Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.8.5 Reata Pharmaceuticals Recent Development
11.9 Stealth Biotherapeutics
11.9.1 Stealth Biotherapeutics Company Details
11.9.2 Stealth Biotherapeutics Business Overview
11.9.3 Stealth Biotherapeutics Mitochondrial Myopathy Diagnosis & Treatment Introduction
11.9.4 Stealth Biotherapeutics Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
11.9.5 Stealth Biotherapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of itochondrial Myopathy Diagnosis
Table 3. Key Players of Mitochondrial Myopathy Treatment
Table 4. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2016-2021)
Table 8. Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2022-2027)
Table 10. Mitochondrial Myopathy Diagnosis & Treatment Market Trends
Table 11. Mitochondrial Myopathy Diagnosis & Treatment Market Drivers
Table 12. Mitochondrial Myopathy Diagnosis & Treatment Market Challenges
Table 13. Mitochondrial Myopathy Diagnosis & Treatment Market Restraints
Table 14. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Players (2016-2021)
Table 16. Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathy Diagnosis & Treatment as of 2020)
Table 17. Ranking of Global Top Mitochondrial Myopathy Diagnosis & Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Mitochondrial Myopathy Diagnosis & Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mitochondrial Myopathy Diagnosis & Treatment Product Solution and Service
Table 21. Date of Enter into Mitochondrial Myopathy Diagnosis & Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Mitochondrial Myopathy Diagnosis & Treatment Product
Table 64. AbbVie Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Centogene Company Details
Table 67. Centogene Business Overview
Table 68. Centogene Mitochondrial Myopathy Diagnosis & Treatment Product
Table 69. Centogene Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 70. Centogene Recent Development
Table 71. GeneDx Company Details
Table 72. GeneDx Business Overview
Table 73. GeneDx Mitochondrial Myopathy Diagnosis & Treatment Product
Table 74. GeneDx Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 75. GeneDx Recent Development
Table 76. Ixchel Pharma Company Details
Table 77. Ixchel Pharma Business Overview
Table 78. Ixchel Pharma Mitochondrial Myopathy Diagnosis & Treatment Product
Table 79. Ixchel Pharma Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 80. Ixchel Pharma Recent Development
Table 81. Khondrion Company Details
Table 82. Khondrion Business Overview
Table 83. Khondrion Mitochondrial Myopathy Diagnosis & Treatment Product
Table 84. Khondrion Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 85. Khondrion Recent Development
Table 86. Mitobridge Company Details
Table 87. Mitobridge Business Overview
Table 88. Mitobridge Mitochondrial Myopathy Diagnosis & Treatment Product
Table 89. Mitobridge Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 90. Mitobridge Recent Development
Table 91. NeuroVive Pharmaceutical Company Details
Table 92. NeuroVive Pharmaceutical Business Overview
Table 93. NeuroVive Pharmaceutical Mitochondrial Myopathy Diagnosis & Treatment Product
Table 94. NeuroVive Pharmaceutical Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 95. NeuroVive Pharmaceutical Recent Development
Table 96. Reata Pharmaceuticals Company Details
Table 97. Reata Pharmaceuticals Business Overview
Table 98. Reata Pharmaceuticals Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 99. Reata Pharmaceuticals Recent Development
Table 100. Stealth Biotherapeutics Company Details
Table 101. Stealth Biotherapeutics Business Overview
Table 102. Stealth Biotherapeutics Mitochondrial Myopathy Diagnosis & Treatment Product
Table 103. Stealth Biotherapeutics Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021) & (US$ Million)
Table 104. Stealth Biotherapeutics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type: 2020 VS 2027
Figure 2. itochondrial Myopathy Diagnosis Features
Figure 3. Mitochondrial Myopathy Treatment Features
Figure 4. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Disease Research and Development Institutes Case Studies
Figure 8. Mitochondrial Myopathy Diagnosis & Treatment Report Years Considered
Figure 9. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2022-2027)
Figure 13. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Players in 2020
Figure 14. Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathy Diagnosis & Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Mitochondrial Myopathy Diagnosis & Treatment Revenue in 2020
Figure 16. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 20. North America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 21. North America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 22. United States Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 26. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 27. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 28. Germany Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Mitochondrial Myopathy Diagnosis & Treatment Market Share by Region (2016-2027)
Figure 38. China Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Mitochondrial Myopathy Diagnosis & Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 58. Centogene Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 59. GeneDx Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 60. Ixchel Pharma Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 61. Khondrion Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 62. Mitobridge Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 63. NeuroVive Pharmaceutical Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 64. Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 65. Stealth Biotherapeutics Revenue Growth Rate in Mitochondrial Myopathy Diagnosis & Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年）

Global Meningitis Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3698 2021年4月 95Pages
QYResearch社発行の本調査資料では、髄膜炎診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性髄膜炎、細菌性髄膜炎、その他）、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のHIV診断・治療市場規模・現状・予測（2021年-2027年）

Global HIV Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2856 2021年4月 95Pages
QYResearch社発行の本調査資料では、HIV診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗体検査、ウイルス同定アッセイ、Cd4検査、ウイルス量検査、乳幼児診断）、用途別市場規模（診断研究所、病院、血液バンク、在宅ケア）、主要...

世界のHIV診断＆治療市場規模・現状・予測（2021年-2027年）

Global HIV Diagnosis & Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2855 2021年4月 90Pages
QYResearch社発行の本調査資料では、HIV診断＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、ア...

世界のてんかん診断・治療市場規模・現状・予測（2021年-2027年）

Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2232 2021年4月 96Pages
QYResearch社発行の本調査資料では、てんかん診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断（神経学的検査、血液検査、画像診断）、治療（医療、外科））、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ...

世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年）

Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0062 2021年4月 98Pages
QYResearch社発行の本調査資料では、急性虚血性脳卒中診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、頸部超音波、脳血管造影、心電図、心エコー検査、その他）、用途別市場規模...

世界のクラミジア診断・治療市場規模・現状・予測（2021年-2027年）

Global Chlamydia Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1290 2021年4月 90Pages
QYResearch社発行の本調査資料では、クラミジア診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クラミジア培養、尿培養、酵素イムノアッセイ、核酸増幅検査）、用途別市場規模（病院、診断センター、研究機関）、主要地域別市場規模（北米...

世界の頭蓋内出血診断・治療市場規模・現状・予測（2021年-2027年）

Global Intracranial Hemorrhage Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3223 2021年4月 90Pages
QYResearch社発行の本調査資料では、頭蓋内出血診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（装置、治療薬、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の十字靭帯診断・治療市場規模・現状・予測（2021年-2027年）

Global Cruciate Ligament Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1659 2021年4月 95Pages
QYResearch社発行の本調査資料では、十字靭帯診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（後十字靭帯（PCL）、前十字靭帯（ACL））、用途別市場規模（病院、整形外科クリニック、外来手術センター（ASC））、主要地域別市場規...

世界の男性不妊症診断・治療市場規模・現状・予測（2021年-2027年）

Global Male Infertility Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3537 2021年4月 90Pages
QYResearch社発行の本調査資料では、男性不妊症診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬・医薬品、手術用マーカー、生殖補助医療（ART））、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米...

世界の食物アレルギー診断・治療市場規模・現状・予測（2021年-2027年）

Global Food Allergy Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2428 2021年4月 99Pages
QYResearch社発行の本調査資料では、食物アレルギー診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プリック検査、血液検査、食物除去検査、ポリメラーゼ連鎖反応（PCR）、酵素免疫測定法（ELISA）、その他）、用途別市場規模（抗...

世界のミトコンドリアミオパチー市場規模・現状・予測（2021年-2027年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
世界のHIV診断＆治療市場規模・現状・予測（2021年-2027年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
世界のHIV診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global HIV Diagnosis and Treatment Market The global HIV Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
世界のてんかん診断・治療市場規模・現状・予測（2021年-2027年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …